The Center for Radiopharmaceutical Sciences (CRS) at ETH Zurich develops new innovative radiolabelled pharmaceuticals for diagnosis and therapy. It offers state of the art infrastructure and equipment to perform research from “bench-to-bedside”.
Radiopharmaceuticals are important molecular probes for the non-invasive detection of diseases with very high sensitivity. At the CRS we are developing and testing novel 18F-labelled radiopharmaceuticals for the detection of neurodegeneration, cardiovascular diseases and cancer. To achieve this goal, we also investigate novel chemistry and radiolabelling protocols.
The mission of our multidisciplinary research focus in organic chemistry and radiochemistry is to develop innovative fluorine-18 radiochemistry for medicine. You will be responsible for exploring novel chemistry in the cold lab, in particular the investigation of novel fluorination methods/reagents and the synthesis of precursors for radiolabelling. Furthermore, you will get trained for performing independently 18F-radiolabelling experiments in the HCI Isotope Labs.
Additionally, you will also be involved in teaching by supervising practical laboratory courses and bachelor/master theses.
Essential:
Desirable:
Key personal characteristics:
chevron_right Working, teaching and research at ETH Zurich
We look forward to receiving your online application with the following documents:
Please note that we exclusively accept applications submitted through our online application portal. Applications via email or postal services will not be considered.
Further information about the Center for Radiopharmaceutical Sciences can be found on our website. Questions regarding the position should be directed to Dr. Stefan Gruber, Tel +41 44 633 68 94 or email stefan.gruber@pharma.ethz.ch (no applications).
For recruitment services the GTC of ETH Zurich apply.
In your application, please refer to Professorpositions.com